Diagnosis and clinical management of Wiskott–Aldrich syndrome: current and emerging techniques

References

• Wiskott A. Familiarer, angeborener Morbus Werlhofii? Monatsschr Kinderheilkd. 1937;68:212–216.
   Google Scholar
• Aldrich RA, Steinberg AG, Campbell DC. Pedigree demonstrating a sex-linked recessive condition characterized by draining ears, eczematoid dermatitis and bloody diarrhea. Pediatrics. 1954 Feb;13:133–139.
   PubMed Web of Science ®Google Scholar
• Derry JM, Ochs HD, Francke U. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell. 1994 Aug 26;78:635–644. DOI:https://doi.org/10.1016/0092-8674(94)90528-2.
   PubMed Web of Science ®Google Scholar
• Imai K, Morio T, Zhu Y, et al. Clinical course of patients with WASP gene mutations. Blood. 2004 Jan 15;103:456–464. DOI:https://doi.org/10.1182/blood-2003-05-1480.
   PubMed Web of Science ®Google Scholar
• Jin Y, Mazza C, Christie JR, et al. Mutations of the Wiskott-Aldrich Syndrome Protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation. Blood. 2004 Dec 15;104:4010–4019. DOI:https://doi.org/10.1182/blood-2003-05-1592.
   PubMed Web of Science ®Google Scholar
• Rivers E, Thrasher AJ. Wiskott-Aldrich syndrome protein: emerging mechanisms in immunity. Eur J Immunol. 2017 Nov;47:1857–1866.
   PubMedGoogle Scholar
• Thrasher AJ, Burns SO. WASP: a key immunological multitasker. Nat Rev Immunol. 2010 Mar;10(3):447–462.
   Google Scholar
• Tangye SG, Bucciol G, Casas‐Martin J, et al. Bleeding and splenectomy in Wiskott-Aldrich syndrome: a single-centre experience. Immunol Cell Biol. 2019 Apr;97(3):389–402.
   PubMedGoogle Scholar
• Sprenkeler EGG, Webbers SDS, Kuijpers TW. When actin is not actin’ like it should: a new category of distinct primary immunodeficiency disorders. J Innate Immun. 2021;13:3–25.
   PubMedGoogle Scholar
• Albert MH, Bittner TC, Nonoyama S, et al. X-linked thrombocytopenia (XLT) due to WAS mutations: clinical characteristics, long-term outcome, and treatment options. Blood. 2010 Apr 22;115(16):3231–3238.
   PubMed Web of Science ®Google Scholar
• Miyazawa H, Wada T. Reversion mosaicism in primary immunodeficiency diseases. Front Immunol. 2021 Nov 16;12:783022. DOI:https://doi.org/10.3389/fimmu.2021.783022.
   PubMedGoogle Scholar
• Davis BR, Dicola MJ, Prokopishyn NL, et al. Unprecedented diversity of genotypic revertants in lymphocytes of a patient with Wiskott-Aldrich syndrome. Blood. 2008 May 15;111:5064–5067. DOI:https://doi.org/10.1182/blood-2007-06-095299.
   PubMedGoogle Scholar
• Devriendt K, Kim AS, Mathijs G, et al. Constitutively activating mutations in WASP causes X-linked severe congenital neutropenia. Nat Genet. 2001;27:313–317. DOI:https://doi.org/10.1038/85886.
   PubMed Web of Science ®Google Scholar
• Mullins RD, Heuser JA, Pollard TD. The interaction of Arp2/3 complex with actin: nucleation, high affinity pointed end capping, and formation of branching networks of filaments. Proc Natl Acad Sci USA. 1998;95:6181–6186.
   PubMed Web of Science ®Google Scholar
• Millard TH, Sharp SJ, Machesky LM. Signaling to actin assembly via the WASP (Wiskott-Aldrich Syndrome Protein)-family proteins and the Arp2/3 complex. Biochem J. 2004 May 15;380:1–17. DOI:https://doi.org/10.1042/bj20040176.
   PubMed Web of Science ®Google Scholar
• Ochs HD, Slichter SJ, Harker LA, et al. The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets. Blood. 1980 Feb;55:243–252. https://doi.org/10.1182/blood.V55.2.243.243.
   PubMed Web of Science ®Google Scholar
• Sarkar K, Han SS, Wen KK, et al. R-loops cause genomic instability in T helper lymphocytes from patients with Wiskott-Aldrich syndrome. J Allergy Clin Immunol. 2018 Jul;142:219–234.
   PubMedGoogle Scholar
• Rengan R, Ochs HD, Sweet LI, et al. Actin cytoskeletal function is spared, but apoptosis is increased, in WAS patient hematopoietic cells. Blood. 2000 Feb 15;95:1283–1292. DOI:https://doi.org/10.1182/blood.V95.4.1283.004k44_1283_1292.
   PubMed Web of Science ®Google Scholar
• Wen KK, Han SS, Vyas YM. Wiskott-Aldrich syndrome protein senses irradiation-induced DNA damage to coordinate the cell-protective Golgi dispersal response in human T and B lymphocytes. J Allergy Clin Immunol. 2020 Jan;145:324–334.
   PubMedGoogle Scholar
• Sun X, Wei Y, Lee PP, et al. The role of WASp in T cells and B cells. Cell Immunol. 2019 Jul;341:103919.
   PubMedGoogle Scholar
• Ngoenkam J, Paensuwan P, Wipa P, et al. Wiskott-Aldrich syndrome protein: roles in signal transduction in T cells. Front Cell Dev Biol. 2021 Jun 8;9:674572. DOI:https://doi.org/10.3389/fcell.2021.674572.
   PubMedGoogle Scholar
• Liu Q, Zhang L, Shu Z, et al. WASp is essential for effector-to-memory conversion and for maintenance of CD8 + T cell memory. Front Immunol. 2019 Sep 24;10:2262. DOI:https://doi.org/10.3389/fimmu.2019.02262.
   PubMedGoogle Scholar
• Recher M, Burns SO, de la Fuente MA, et al. B cell-intrinsic deficiency of the Wiskott-Aldrich syndrome protein (WASp) causes severe abnormalities of the peripheral B-cell compartment in mice. Blood. 2012 Mar 22;119:2819–2828. DOI:https://doi.org/10.1182/blood-2011-09-379412.
   PubMed Web of Science ®Google Scholar
• Westerberg LS, Dahlberg C, Baptista M, et al. Wiskott-Aldrich syndrome protein (WASP) and N-WASP are critical for peripheral B-cell development and function. Blood. 2012 Apr 26;119(17):3966–3974.
   PubMedGoogle Scholar
• Volpi S, Santori E, Abernethy K, et al. N-WASP is required for B-cell-mediated autoimmunity in Wiskott-Aldrich syndrome. Blood. 2016 Jan 14;127:216–220. DOI:https://doi.org/10.1182/blood-2015-05-643817.
   PubMed Web of Science ®Google Scholar
• Rey-Suarez I, Wheatley BA, Koo P, et al. WASP family proteins regulate the mobility of the B cell receptor during signaling activation. Nat Commun. 2020 Jan 23;11:439. DOI:https://doi.org/10.1038/s41467-020-14335-8.
   PubMedGoogle Scholar
• Stabile H, Carlino C, Mazza C, et al. Impaired NK-cell migration in WAS/XLT patients: role of Cdc42/WASp pathway in the control of chemokine-induced beta2 integrin high-affinity state. Blood. 2010 Apr 8;115:2818–2826. DOI:https://doi.org/10.1182/blood-2009-07-235804.
   PubMed Web of Science ®Google Scholar
• Orange JS, Ramesh N, Remold-O’Donnell E, et al. Wiskott-Aldrich syndrome protein is required for NK cell cytotoxicity and colocalizes with actin to NK cell-activating immunologic synapses. Proc Natl Acad Sci U S A. 2002 Aug 20;99:11351–11356. DOI:https://doi.org/10.1073/pnas.162376099.
   PubMed Web of Science ®Google Scholar
• Zicha D, Allen WE, Brickell PM, et al. Chemotaxis of macrophages is abolished in the Wiskott-Aldrich syndrome. Br J Haematol. 1998 Jun;101:659–665.
   PubMedGoogle Scholar
• Dart AE, Donnelly SK, Holden DW, et al. Nck and Cdc42 co-operate to recruit N-WASP to promote FcγR-mediated phagocytosis. J Cell Sci. 2012;125:2825–2830.
   PubMedGoogle Scholar
• Malinova D, Fritzsche M, Nowosad CR, et al. WASp-dependent actin cytoskeleton stability at the dendritic cell immunological synapse is required for extensive, functional T cell contacts. J Leukoc Biol. 2016 May;99:699–710.
   PubMed Web of Science ®Google Scholar
• Humblet-Baron S, Sather B, Anover S, et al. Wiskott-Aldrich syndrome protein is required for regulatory T cell homeostasis. J Clin Invest. 2007 Feb;117:407–418.
   PubMed Web of Science ®Google Scholar
• Sereni L, Castiello MC, Marangoni F, et al. Autonomous role of Wiskott-Aldrich syndrome platelet deficiency in inducing autoimmunity and inflammation. J Allergy Clin Immunol. 2018 Oct;142:1272–1284.
   PubMedGoogle Scholar
• Piperno GM, Naseem A, Silvestrelli G, et al. Wiskott-Aldrich syndrome protein restricts cGAS/STING activation by dsDNA immune complexes. JCI Insight. 2020 Sep 3;5:e132857. DOI:https://doi.org/10.1172/jci.insight.132857.
   PubMedGoogle Scholar
• Lee PP, Lobato-Márquez D, Pramanik N, et al. Wiskott-Aldrich syndrome protein regulates autophagy and inflammasome activity in innate immune cells. Nat Commun. 2017 Nov 17;8:1576. DOI:https://doi.org/10.1038/s41467-017-01676-0.
   PubMedGoogle Scholar
• Obydennyi SI, Artemenko EO, Sveshnikova AN, et al. Mechanisms of increased mitochondria-dependent necrosis in Wiskott-Aldrich syndrome platelets. Haematologica. 2020 Apr;105:1095–1106.
   PubMed Web of Science ®Google Scholar
• Maffeis M, Notarangelo LD, Schumacher RF, et al. Primary immunodeficiencies and oncological risk: the experience of the children’s hospital of Brescia. Front Pediatr. 2019 Jun 19;7:232. DOI:https://doi.org/10.3389/fped.2019.00232.
   PubMedGoogle Scholar
• Boonyawat B, Dhanraj S, Al Abbas F, et al. Combined de-novo mutation and non-random X-chromosome inactivation causing Wiskott-Aldrich syndrome in a female with thrombocytopenia. Clin Immunol. 2013 Oct;33:1150–1155.
   Google Scholar
• Sullivan KE, Mullen CA, Blaese RM, et al. A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr. 1994 Dec;125:876–885. DOI:https://doi.org/10.1016/S0022-3476(05)82002-5.
   PubMed Web of Science ®Google Scholar
• Jin YY, Wu J, Chen TX, et al. When WAS gene diagnosis is needed: seeking clues through comparison between patients with Wiskott-Aldrich syndrome and idiopathic thrombocytopenic purpura. Front Immunol. 2019 Jul 9;10:1549. DOI:https://doi.org/10.3389/fimmu.2019.01549.
   PubMed Web of Science ®Google Scholar
• Fehervari Z. Allergy in Wiskott-Aldrich syndrome. Nat Immunol. 2016 Oct 19;17:1243.
   Google Scholar
• Stadler PC, Renner ED, Milner J, et al. Inborn error of immunity or atopic dermatitis: when to be concerned and how to investigate. J Allergy Clin Immunol Pract. 2021 Apr;9:1501–1507.
   PubMedGoogle Scholar
• Kumar A, Jain S, Kumar P, et al. Generalised eczema: a diagnostic clue to Wiskott-Aldrich syndrome. BMJ Case Rep. 2021 Jun 21;14:e242642. DOI:https://doi.org/10.1136/bcr-2021-242642.
   PubMedGoogle Scholar
• Dupuis-Girod S, Medioni J, Haddad E, et al. Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients. Pediatrics. 2003 May;111:e622–7.
   PubMed Web of Science ®Google Scholar
• Catucci M, Castiello MC, Pala F, et al. Autoimmunity in wiskott-Aldrich syndrome: an unsolved enigma. Front Immunol. 2012 Jul 18;3:209. DOI:https://doi.org/10.3389/fimmu.2012.00209.
   PubMed Web of Science ®Google Scholar
• Cheminant M, Mahlaoui N, Desconclois C, et al. Lymphoproliferative disease in patients with Wiskott-Aldrich syndrome: analysis of the French registry of primary immunodeficiencies. J Allergy Clin Immunol. 2019 Jun;143:2311–2315.e7.
   PubMedGoogle Scholar
• Patel PD, Samanich JM, Mitchell WB, et al. A unique presentation of Wiskott-Aldrich syndrome in relation to platelet size. Pediatr Blood Cancer. 2011 Jul 1;56:1127–1129. DOI:https://doi.org/10.1002/pbc.22920.
   PubMed Web of Science ®Google Scholar
• Wada T, Itoh M, Maeba H, et al. Intermittent X-linked thrombocytopenia with a novel WAS gene mutation. Pediatr Blood Cancer. 2014 Apr;61:746–748.
   PubMedGoogle Scholar
• Crestani E, Volpi S, Candotti F, et al. Broad spectrum of autoantibodies in patients with Wiskott-Aldrich syndrome and X-linked thrombocytopenia. J Allergy Clin Immunol. 2015 Nov;136:1401–4.e1–3.
   Google Scholar
• Cervantes-Luevano KE, Caronni N, Castiello MC, et al. Neutrophils drive type I interferon production and autoantibodies in patients with Wiskott-Aldrich syndrome. J Allergy Clin Immunol. 2018 Nov;142:1605–1617.e4.
   PubMedGoogle Scholar
• Rivers E, Hong Y, Bajaj-Elliott M, et al. IL-18: A potential inflammation biomarker in Wiskott-Aldrich syndrome. Eur J Immunol. 2021 May;51:1285–1288.
   PubMedGoogle Scholar
• Korsunskiy I, Blyuss O, Gordukova M, et al. Expanding TREC and KREC utility in primary immunodeficiency diseases diagnosis. Front Immunol. 2020 Mar 3;11:320. DOI:https://doi.org/10.3389/fimmu.2020.00320.
   PubMedGoogle Scholar
• Borte S, Fasth A, von Döbeln U, et al. Newborn screening for severe T and B cell lymphopenia identifies a fraction of patients with Wiskott-Aldrich syndrome. Clin Immunol. 2014 Nov;155:74–78.
   PubMedGoogle Scholar
• Collins CJ, Chang IJ, Jung S, et al. Rapid multiplexed proteomic screening for primary immunodeficiency disorders from dried blood spots. Front Immunol. 2018 Dec 4;9:2756. DOI:https://doi.org/10.3389/fimmu.2018.02756.
   PubMed Web of Science ®Google Scholar
• Collins CJ, Yi F, Dayuha R, et al. Multiplexed proteomic analysis for diagnosis and screening of five primary immunodeficiency disorders from dried blood spots. Front Immunol. 2020 Apr 1;11:464. DOI:https://doi.org/10.3389/fimmu.2020.00464.
   PubMedGoogle Scholar
• Takashima T, Okamura M, Yeh TW, et al. Multicolor flow cytometry for the diagnosis of primary immunodeficiency diseases. J Clin Immunol. 2017 Jul;37:486–495.
   PubMed Web of Science ®Google Scholar
• Yamada M, Ariga T, Kawamura N, et al. Determination of carrier status for the Wiskott-Aldrich syndrome by flow cytometric analysis of Wiskott-Aldrich syndrome protein expression in peripheral blood mononuclear cells. J Immunol. 2000 Jul 15;165:1119–1122. DOI:https://doi.org/10.4049/jimmunol.165.2.1119.
   PubMedGoogle Scholar
• Yamaguchi K, Ariga T, Yamada M, et al. Mixed chimera status of 12 patients with Wiskott-Aldrich syndrome (WAS) after hematopoietic stem cell transplantation: evaluation by flow cytometric analysis of intracellular WAS protein expression. Blood. 2002 Aug 15;100:1208–1214. DOI:https://doi.org/10.1182/blood-2002-01-0211.
   PubMed Web of Science ®Google Scholar
• Chiang SCC, Vergamini SM, Husami A, et al. Screening for Wiskott-Aldrich syndrome by flow cytometry. J Allergy Clin Immunol. 2018 Jul;142:333–5.e8.
   PubMedGoogle Scholar
• Notarangelo LD, Mazza C, Giliani S, et al. Missense mutations of the WASP gene cause intermittent X-linked thrombocytopenia. Blood. 2002 Mar 15;99:2268–2269. DOI:https://doi.org/10.1182/blood.V99.6.2268.
   PubMed Web of Science ®Google Scholar
• Boers SA, Jansen R, Hays JP. Understanding and overcoming the pitfalls and biases of next-generation sequencing (NGS) methods for use in the routine clinical microbiological diagnostic laboratory. Eur J Clin Microbiol Infect Dis. 2019 Jun;38:1059–1070.
   PubMedGoogle Scholar
• Kurekci E, Küpesiz A, Anak S, et al. Hematopoietic stem cell transplantation using preimplantation genetic diagnosis and human leukocyte antigen typing for human leukocyte antigen–matched sibling donor: a Turkish multicenter study. Biol Blood Marrow Transplant. 2017 May;23(5):790–794.
   PubMed Web of Science ®Google Scholar
• Zhu Q, Watanabe C, Liu T, et al. Wiskott-Aldrich syndrome/X-linked thrombocytopenia: WASP gene mutations, protein expression, and phenotype. Blood. 1997 Oct 1;90:2680–2689. DOI:https://doi.org/10.1182/blood.V90.7.2680.
   PubMed Web of Science ®Google Scholar
• Buchbinder D, Nadeau K, Nugent D. Monozygotic twin pair showing discordant phenotype for X-linked thrombocytopenia and Wiskott-Aldrich syndrome: a role for epigenetics? J Clin Immunol. 2011 Oct;31:773–777.
   PubMed Web of Science ®Google Scholar
• Litzman J, Jones A, Hann I, et al. Intravenous immunoglobulin, splenectomy, and antibiotic prophylaxis in Wiskott-Aldrich syndrome. Arch Dis Child. 1996 Nov;75:436–439.
   PubMed Web of Science ®Google Scholar
• Conley ME, Saragoussi D, Notarangelo L, et al. An international study examining therapeutic options used in treatment of Wiskott–Aldrich syndrome. Clin Immunol. 2003 Dec;109(3):272–277.
   PubMedGoogle Scholar
• Jyonouchi S, Gwafila B, Gwalani LA, et al. Phase I trial of low-dose interleukin 2 therapy in patients with Wiskott-Aldrich syndrome. Clin Immunol. 2017 Jun;179:47–53.
   PubMedGoogle Scholar
• Dinarello CA, Novick D, Kim S, et al. Interleukin-18 and IL-18 binding protein. Front Immunol. 2013 Oct 8;4:289. DOI:https://doi.org/10.3389/fimmu.2013.00289.
   PubMed Web of Science ®Google Scholar
• Mathew P, Conley ME. Effect of intravenous gammaglobulin (IVIG) on the platelet count in patients with Wiskott-Aldrich syndrome. Pediatr Allergy Immunol. 1995 May;6(2):91–94.
   PubMedGoogle Scholar
• Ozsahin H, Cavazzana-Calvo M, Notarangelo LD, et al. Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European society for immunodeficiencies and European group for blood and marrow transplantation. Blood. 2008 Jan 1;111(1):439–445.
   PubMed Web of Science ®Google Scholar
• Gerrits AJ, Leven EA, Frelinger AL, et al. Effects of eltrombopag on platelet count and platelet activation in Wiskott-Aldrich syndrome/X-linked thrombocytopenia. Blood. 2015 Sep 10;126(11):1367–1378.
   PubMed Web of Science ®Google Scholar
• Zaninetti C, Gresele P, Bertomoro A, et al. Eltrombopag for the treatment of inherited thrombocytopenias: a phase II clinical trial. Haematologica. 2020 Mar;105(3):820–828.
   PubMed Web of Science ®Google Scholar
• Khoreva A, Abramova I, Deripapa E, et al. Efficacy of romiplostim in treatment of thrombocytopenia in children with Wiskott–Aldrich syndrome. Br J Haematol. 2021 Jan;192(2):1–17.
   Google Scholar
• Burroughs LM, Petrovic A, Brazauskas R, et al. Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report. Blood. 2020 Jun 4;135(23):2094–2105.
   PubMed Web of Science ®Google Scholar
• Albert MH, Slatter MA, Gennery AR, et al. Hematopoietic stem cell transplantation for Wiskott-Aldrich syndrome: an EBMT inborn errors working party analysis. Blood. 2022 Jan 31;135:2021014687.
   Google Scholar
• Iguchi A, Cho Y, Yabe H, et al. Long-term outcome and chimerism in patients with Wiskott–Aldrich syndrome treated by hematopoietic cell transplantation: a retrospective nationwide survey. Int J Hematol. 2019 Sep;110(3):364–369.
   PubMedGoogle Scholar
• Balashov D, Laberko A, Shcherbina A, et al. A conditioning regimen with plerixafor is safe and improves the outcome of TCRαβ+ and CD19+ cell-depleted stem cell transplantation in patients with Wiskott-Aldrich syndrome. Biol Blood Marrow Transplant. 2018 Jul;24(7):1432–1440.
   PubMed Web of Science ®Google Scholar
• Elfeky RA, Furtado-Silva JM, Chiesa R, et al. One hundred percent survival after transplantation of 34 patients with Wiskott-Aldrich syndrome over 20 years. J Allergy Clin Immunol. 2018 Nov;142(5):1654–56.e7.
   PubMed Web of Science ®Google Scholar
• Yue Y, Shi X, Song Z, et al. Posttransplant cyclophosphamide for haploidentical stem cell transplantation in children with Wiskott-Aldrich syndrome. Pediatr Blood Cancer. 2018 Aug;65(8):e27092.
   PubMed Web of Science ®Google Scholar
• Ngwube A, Hanson IC, Orange J, et al. Outcomes after allogeneic transplant in patients with Wiskott-Aldrich syndrome. Biol Blood Marrow Transplant. 2018 Mar;24(3):1857–1866.
   Google Scholar
• Thakkar D, Katewa S, Rastogi N, et al. Successful reduced intensity conditioning alternate donor stem cell transplant for Wiskott-Aldrich syndrome. J Pediatr Hematol Oncol. 2017 Nov;39(8):e493–6.
   PubMedGoogle Scholar
• Shekhovtsova Z, Bonfim C, Ruggeri A, et al. A risk factor analysis of outcomes after unrelated cord blood transplantation for children with Wiskott-Aldrich syndrome. Haematologica. 2017 Jun;102(6):1112–1119.
   PubMed Web of Science ®Google Scholar
• Oshima K, Imai K, Albert MH, et al. Hematopoietic stem cell transplantation for X-linked thrombocytopenia with mutations in the WAS gene. J Clin Immunol. 2015 Jan;35(1):15–21.
   PubMed Web of Science ®Google Scholar
• Shah AJ, Sokolic R, Logan B, et al. Quality of life of patients with Wiskott Aldrich syndrome and X-linked thrombocytopenia: a study of the primary immune deficiency consortium (PIDTC), immune deficiency foundation, and the Wiskott-Aldrich foundation. J Clin Immunol. 2019 Nov;39(8):786–794.
   PubMedGoogle Scholar
• Mallhi KK, Petrovic A, Ochs HD. Hematopoietic stem cell therapy for Wiskott–Aldrich syndrome: improved outcome and quality of life. J Blood Med. 2021 Jun 11;23:790–794. DOI:https://doi.org/10.2147/JBM.S232650.
   Google Scholar
• Filipovich AH, Stone JV, Tomany SC, et al. Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the international bone marrow transplant registry and the national marrow donor program. Blood. 2001 Mar 15;97(6):1598–1603.
   PubMed Web of Science ®Google Scholar
• Flowers MED, Parker PM, Johnston LJ, et al. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial. Blood. 2002 Jul 15;100(2):415–419.
   PubMed Web of Science ®Google Scholar
• Moratto D, Giliani S, Bonfim C, et al. Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative study. Blood. 2011 Aug 11;118(6):1675–1684.
   PubMed Web of Science ®Google Scholar
• Lum SH, Elfeky R, Achini FR, et al. Outcome of non-hematological autoimmunity after hematopoietic cell transplantation in children with primary immunodeficiency. J Clin Immunol. 2021 Jan;41(1):1272–1284.
   PubMedGoogle Scholar
• Lum SH, Selvarajah S, Deya-Martinez A, et al. Outcome of autoimmune cytopenia after hematopoietic cell transplantation in primary immunodeficiency. J Allergy Clin Immunol. 2020;146(2):406–416.
   PubMedGoogle Scholar
• Kamani NR, Kumar S, Hassebroek A, et al. Malignancies after hematopoietic cell transplantation for primary immune deficiencies: a report from the center for international blood and marrow transplant research. Biol Blood Marrow Transplant. 2011 Dec;17(12):1783–1789.
   PubMed Web of Science ®Google Scholar
• Kohn LA, Kohn DB. Gene therapies for primary immune deficiencies. Front Immunol. 2021 Feb 25;12:648951. DOI:https://doi.org/10.3389/fimmu.2021.648951.
   PubMedGoogle Scholar
• Hacein-Bey Abina S, Gaspar HB, Blondeau J, et al. Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome. Jama. 2015 Apr 21;313(15):1550–1563.
   PubMed Web of Science ®Google Scholar
• Aiuti A, Biasco L, Scaramuzza S, et al. Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome. Science. 2013 Aug;341(6148):1233151.
   PubMed Web of Science ®Google Scholar
• Labrosse R, Chu J, Armant M, et al. Outcome of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome. Blood. 2019;134(Supplement_1):4629.
   Web of Science ®Google Scholar
• Ferrua F, Cicalese MP, Galimberti S, et al. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study. Lancet Haematol. 2019;6:e239–53 .
   PubMed Web of Science ®Google Scholar
• Ferrua F, Cicalese MP, Galimberti S, et al. Lentiviral hematopoietic stem and progenitor cell gene therapy for Wiskott-Aldrich syndrome (WAS): up to 8 years of follow up in 17 subjects treated since 2010. Blood. 2019;134(Supplement_1):3346.
   Google Scholar
• Boztug K, Schmidt M, Schwarzer A, et al. Stem-cell gene therapy for the Wiskott–Aldrich syndrome. N Engl J Med. 2010 Nov 11;363(20):1918–1927.
   PubMed Web of Science ®Google Scholar
• Braun CJ, Boztug K, Paruzynski A, et al. Gene therapy for Wiskott-Aldrich syndrome–long-term efficacy and genotoxicity. Sci Transl Med. 2014 Mar 12;6:227ra33.
   PubMed Web of Science ®Google Scholar
• Cavazzana M, Bushman FD, Miccio A, et al. Gene therapy targeting haematopoietic stem cells for inherited diseases: progress and challenges. Nat Rev Drug Discov. 2019 Jun;18(6):447–462.
   PubMed Web of Science ®Google Scholar
• Morris EC, Fox T, Chakraverty R, et al. Gene therapy for Wiskott-Aldrich syndrome in a severely affected adult. Blood. 2017 Sep 14;130(11):1327–1335.
   PubMed Web of Science ®Google Scholar
• Magnani A, Semeraro M, Adam F, et al. Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott-Aldrich syndrome. Nat Med. 2022 Jan;28:71–80. https://doi.org/10.1038/s41591-021-01641-x.
   PubMedGoogle Scholar
• Sereni L, Castiello MC, Di Silvestre D, et al. Lentiviral gene therapy corrects platelet phenotype and function in patients with Wiskott-Aldrich syndrome. J Allergy Clin Immunol. 2019 Sep;144:825–838.
   PubMed Web of Science ®Google Scholar
• Rai R, Romito M, Rivers E, et al. Targeted gene correction of human hematopoietic stem cells for the treatment of Wiskott - Aldrich syndrome. Nat Commun. 2020 Aug 12;11:4034. DOI:https://doi.org/10.1038/s41467-020-17626-2.
   PubMed Web of Science ®Google Scholar